With a brand-name medication, the manufacturer is a known quantity and every pill or pen meets the same approved specification. With compounded medication, none of that applies — the compounding pharmacy is the manufacturer, and quality varies with it. That is why this ranking weights pharmacy disclosure above price.
What Actually Matters With Compounded
Compounded GLP-1s are not FDA-approved and are not generic equivalents of Wegovy, Ozempic, Zepbound, or Mounjaro. They are prepared by compounding pharmacies against a prescription. Because there is no approved product specification behind them, the things that determine what you actually receive are different from what you would evaluate for a brand-name drug.
Our ranking criteria for compounded providers
- Pharmacy disclosure. Does the provider name the compounding pharmacy, or at minimum state the facility category?
- Price stability across doses. Does the advertised price hold as you titrate up, or is it a starting-dose figure?
- Clinical screening. Published eligibility criteria, contraindication screening, and whether a real consultation happens.
- Policy clarity. Cancellation and refund terms, especially on multi-month plans.
- Support during titration. Access to a clinician when a dose increase goes badly.
The Pharmacy Question
Compounding pharmacies operate under two different regulatory regimes, and the distinction is worth understanding before you buy.
503B outsourcing facilities
- Register with the FDA
- Subject to federal inspection
- Must follow current good manufacturing practice requirements
- Can compound in larger batches
503A compounding pharmacies
- Regulated by state pharmacy boards
- Compound patient-specific prescriptions
- Different oversight standards from 503B
- Not subject to the same federal manufacturing requirements
Both are legal routes and both are used widely. They are not equivalent in oversight, however, which is why a provider that tells you which one your medication comes from is giving you something meaningful.
Who discloses what: Precision Telemed names its pharmacies outright (Rush Pharmacy and Greenwich Pharmacy, described as NABP-accredited and FDA-registered). BrightMeds states the facility categories without naming pharmacies. The rest of the providers here disclose neither.
Should You Choose Compounded at All?
This deserves an honest answer before the ranking, because the case for compounded medication has weakened considerably.
The compounded GLP-1 market exists because brand-name drugs were unaffordable without insurance. That premise held when Wegovy cost over $1,000 a month at retail. It holds much less well now that NovoCare Pharmacy sells brand-name Wegovy and Ozempic from $149/month — a price that undercuts several compounded programs outright.
Where compounded still makes sense:
- You want tirzepatide and lack insurance coverage. There is no cheap manufacturer-direct route for tirzepatide, so compounded at $166–$239/month is a genuine cost saving over brand-name.
- You want the prescriber and medication bundled. If arranging a separate prescription is a real barrier, an all-in program has practical value.
- You need a formulation the approved products do not offer. Some patients need a delivery format or dose that is not commercially available.
Where it makes less sense: paying more than $149/month for compounded semaglutide, when the FDA-approved product is available at that price. Our full comparison covers the trade-offs.
Compounded GLP-1 Providers Ranked
All 8 providers below offer compounded GLP-1 medication, ranked by our overall editorial rating. Note that several also offer brand-name options, which is a point in their favour rather than against.
Midi Health
compounded doses cited from $34/week for eligible patients; medication cost depends on your plan
Our editorial rating: 4.4 / 5
An insurance-based midlife and menopause practice with real 30-minute clinician visits and pharmacy choice.
Stands out for: Genuinely insurance-billed care with no membership fee for qualifying patients.
Main caveat: Your actual cost depends entirely on your plan, and "qualifying" is not defined publicly.
- Membership: None for qualifying insured patients
- Insurance: Accepted
- Availability: Offered by employers in all 50 states
Precision Telemed
From $139.99/month — compounded semaglutide; $179.99 tirzepatide; same price at every dose
Our editorial rating: 4.4 / 5
Cash-pay compounded GLP-1 with flat dose pricing, named pharmacies, and a live Zoom visit.
Stands out for: Names its compounding pharmacies and charges the same price at every dose.
Main caveat: Compounded only, injectables only, and a $50 consultation fee on top.
- Membership: None — no subscription required
- Insurance: Not accepted
- Availability: All 50 states
Shapely
From $99/month — compounded semaglutide; $166 tirzepatide; membership is separate
Our editorial rating: 4.3 / 5
Insurance verification first, with a cheap compounded fallback and monthly dietitian visits.
Stands out for: Checks your coverage before you commit, and includes a credentialed dietitian.
Main caveat: Only four states, and the membership fee stacks on top of medication.
- Membership: $99/month standard, promotional rates advertised
- Insurance: Accepted
- Availability: California, Florida, New York, Texas only
Zealthy
From $151/month — compounded semaglutide on a quarterly plan; brand-name from $25 with insurance
Our editorial rating: 4.1 / 5
Runs both an insurance pathway to brand-name GLP-1s and a cash-pay compounded option.
Stands out for: 24/7 licensed provider access included at no extra cost, on either pathway.
Main caveat: The lowest price requires a quarterly commitment, and cancellation terms are unpublished.
- Membership: Bundled into the monthly price
- Insurance: Accepted
- Availability: Not published
Alloy Women's Health
no prices published
Our editorial rating: 4 / 5
Menopause-focused telehealth with an unusually broad brand-name and compounded GLP-1 lineup.
Stands out for: Six medication options including compounded liraglutide, plus HSA/FSA cards accepted directly.
Main caveat: No prices published anywhere on the site.
- Membership: Not published
- Insurance: Not accepted
- Availability: Not published
Shed
From $159/month — compounded semaglutide; $239 compounded tirzepatide
Our editorial rating: 4 / 5
The widest range of GLP-1 delivery formats, with a full care team and a 120-day guarantee.
Stands out for: Needle-free options — oral drops and lozenges — alongside injections and brand-name pens.
Main caveat: Compounded oral drops and lozenges have a thinner evidence base than injections.
- Membership: Not published separately
- Insurance: Not accepted
- Availability: Not published
24hrDoc
From $149/month — compounded injectable semaglutide on sale; $179 oral; $239 tirzepatide
Our editorial rating: 3.9 / 5
Injectable and oral compounded semaglutide plus tirzepatide, with unlimited provider chat.
Stands out for: Publishes real eligibility criteria including the thyroid cancer contraindication.
Main caveat: Every price is framed as a discount off a higher list price, with no clarity on the ongoing rate.
- Membership: None stated
- Insurance: Not accepted
- Availability: Most US states
BrightMeds
no prices published
Our editorial rating: 3.6 / 5
Compounded GLP-1s with dedicated microdosing products, plus FDA-approved Zepbound pens and vials.
Stands out for: Discloses its 503B and 503A facility categories and refunds in full if you are not approved.
Main caveat: No prices published, and microdosing has limited clinical evidence.
- Membership: Not stated
- Insurance: Not accepted
- Availability: Not published
Pre-Purchase Checklist
Before you buy compounded GLP-1 medication from anyone, get written answers to these:
- Which pharmacy compounds my medication, and is it a 503A or 503B facility? If they will not say, that is your answer about how much scrutiny they expect.
- What is the beyond-use date on the vial I will receive? Compounded medication expires much sooner than manufactured product — critical if you are buying a multi-month supply.
- Does the price change as my dose increases? Titration means most people end up above their starting dose.
- What happens if my shipment arrives warm? Ask about the cold-chain replacement policy and the reporting window. See our storage guide.
- What are the cancellation and refund terms? Particularly on quarterly plans.
- Is anything added to the formulation? Some compounded products include additional ingredients that are not in the approved drug.
Frequently Asked Questions
Is compounded semaglutide legal?
Compounding by a licensed pharmacy against a valid prescription is a legal practice. That is different from saying a compounded product is FDA-approved — it is not, and it has not been through the approval process.
Is compounded medication the same strength as brand-name?
Not necessarily, and dosing is not automatically interchangeable. Never switch between compounded and brand-name products, or between compounding pharmacies, without your prescriber managing the change.
Which compounded provider is cheapest?
Shapely publishes the lowest medication price at $99/month, but adds a separate membership. Precision Telemed at $139.99/month with no membership is typically cheaper all-in. See our cheapest programs ranking.
Are compounded oral drops or lozenges effective?
They have a thinner evidence base than injections. The FDA-approved oral semaglutide products are formulations specifically engineered for oral absorption, which compounded drops and lozenges are not. Discuss with a prescriber before choosing one.
Can I use HSA or FSA funds for compounded medication?
Generally yes — FDA-approval status is not the eligibility test. A prescribed medication dispensed by a licensed pharmacy qualifies. The obstacle is usually documentation and merchant coding. See our HSA/FSA guide.
Medical disclaimer: This page is general consumer information, not medical advice. Compounded GLP-1 medications are not FDA-approved. Whether any GLP-1 treatment is appropriate for you, and in what form, is a decision only a licensed healthcare provider who knows your medical history can make. Prices are from published materials as of August 5, 2026 and change frequently.